MDAS implemented the Cybernics Therapy in end October 2024. The hybrid assistive technology works on the users in rediscovering their dormant muscles and regaining confidence in their movements.
Cybernics Therapy leverages advanced medical technology to detect bioelectrical signals from the skin above the muscles. When a user attempts to move, the brain sends a command signal to the muscles. Though faint, this signal that reflects the user’s intent is detected by sensors on the device. Cybernics Therapy uses these signals to assist with movements by enabling wearers to exercise with voluntary commands.
Traditionally, physiotherapy has been a passive form of manual exercises to maintain muscles from deterioration. With Cybernics Therapy, however, the user’s own muscle signals to guide the device, making exercises active and meaningful. It is a groundbreaking feat in therapy and technology.
Barely three months, we have assessed over 20 keen users and delivered more than 100 therapy sessions. We have received remarkable feedback that affirms our decision to introduce the Hybrid Assistive Limb Single Joint as alternative treatments to persons with muscular dystrophy, neuro-muscular conditions and beyond.